Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 50% ± 14% | |
lung | 18 studies | 53% ± 15% | |
intestine | 13 studies | 42% ± 18% | |
kidney | 9 studies | 51% ± 13% | |
brain | 9 studies | 30% ± 9% | |
eye | 8 studies | 42% ± 19% | |
liver | 6 studies | 44% ± 21% | |
pancreas | 5 studies | 65% ± 24% | |
bone marrow | 5 studies | 37% ± 13% | |
uterus | 5 studies | 61% ± 16% | |
lymph node | 5 studies | 52% ± 9% | |
placenta | 4 studies | 62% ± 24% | |
prostate | 4 studies | 42% ± 9% | |
breast | 4 studies | 61% ± 11% | |
adrenal gland | 3 studies | 47% ± 10% | |
esophagus | 3 studies | 56% ± 24% | |
skin | 3 studies | 49% ± 12% | |
thymus | 3 studies | 69% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 6406.55 | 258 / 258 | 100% | 162.26 | 230 / 230 |
bladder | 100% | 6119.71 | 21 / 21 | 100% | 134.11 | 504 / 504 |
brain | 100% | 9372.95 | 2642 / 2642 | 100% | 149.21 | 705 / 705 |
esophagus | 100% | 6047.67 | 1445 / 1445 | 100% | 95.18 | 183 / 183 |
kidney | 100% | 7352.62 | 89 / 89 | 100% | 125.43 | 901 / 901 |
ovary | 100% | 5099.56 | 180 / 180 | 100% | 133.36 | 430 / 430 |
prostate | 100% | 5396.82 | 245 / 245 | 100% | 146.38 | 502 / 502 |
stomach | 100% | 4359.97 | 359 / 359 | 100% | 148.25 | 286 / 286 |
thymus | 100% | 5439.45 | 653 / 653 | 100% | 137.98 | 605 / 605 |
uterus | 100% | 5362.40 | 170 / 170 | 100% | 119.96 | 459 / 459 |
skin | 100% | 5401.89 | 1808 / 1809 | 100% | 109.10 | 472 / 472 |
intestine | 100% | 6177.05 | 966 / 966 | 100% | 158.15 | 526 / 527 |
breast | 100% | 5821.08 | 459 / 459 | 100% | 134.41 | 1115 / 1118 |
lung | 100% | 4741.84 | 576 / 578 | 100% | 97.26 | 1155 / 1155 |
liver | 100% | 3308.50 | 225 / 226 | 100% | 79.23 | 406 / 406 |
pancreas | 99% | 2618.96 | 326 / 328 | 100% | 112.09 | 178 / 178 |
adipose | 100% | 5825.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7253.52 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 111.46 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 117.43 | 29 / 29 |
muscle | 100% | 7299.78 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4210.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 92.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 81.61 | 1 / 1 |
heart | 99% | 5398.27 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 3195.26 | 861 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006397 | Biological process | mRNA processing |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0008380 | Biological process | RNA splicing |
GO_0048025 | Biological process | negative regulation of mRNA splicing, via spliceosome |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0016607 | Cellular component | nuclear speck |
GO_0035145 | Cellular component | exon-exon junction complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0061574 | Cellular component | ASAP complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SAP18 |
Protein name | 18 kDa Sin3-associated polypeptide Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (2HOR0202) (Cell growth-inhibiting gene 38 protein) (Sin3-associated polypeptide p18) |
Synonyms | GIG38 |
Description | FUNCTION: Component of the SIN3-repressing complex. Enhances the ability of SIN3-HDAC1-mediated transcriptional repression. When tethered to the promoter, it can direct the formation of a repressive complex to core histone proteins. Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP and PSAP complexes which bind RNA in a sequence-independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets. The ASAP complex can inhibit mRNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits the formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function. . |
Accessions | ENST00000607003.5 [O00422-1] ENST00000450573.5 U3KPY7 ENST00000492245.5 ENST00000467636.1 ENST00000382533.9 [O00422-2] H7BZW6 U3KQ12 O00422 ENST00000621421.4 [O00422-2] |